Intraocular pressure changes: An important determinant of the biocompatibility of intravitreous implants

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Zou, Ling ^a   Nair, Ashwin ^a   Weng, Hong ^a   Tsai, Yi Ting ^a   Hu, Zhibing ^b   Tang, Liping ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CD11B ANTIGEN; HYALURONIC ACID; NANOPARTICLE; POLY(N ISOPROPYLACRYLAMIDE); POLYLACTIC ACID; POLYSTYRENE; ACRYLIC ACID RESIN; FLUORESCEIN ISOTHIOCYANATE; POLY N ISOPROPYLACRYLAMIDE; POLY-N-ISOPROPYLACRYLAMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HISTOLOGY; IMPLANTATION; INFLAMMATORY CELL; INTRAOCULAR PRESSURE; MATERIALS TESTING; NONHUMAN; PHYSICAL CHEMISTRY; PRESSURE MEASUREMENT; TRABECULAR MESHWORK; ANIMAL; CORNEA; DRUG EFFECT; IMPLANT; INFLAMMATION; INTRAVITREAL DRUG ADMINISTRATION; IRIS; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY; RABBIT; VISUAL PROSTHESIS; VITREOUS BODY;

ACRYLIC RESINS; ANIMALS; ANTIGENS, CD11B; BIOCOMPATIBLE MATERIALS; CORNEA; EYE, ARTIFICIAL; FLUORESCEIN-5-ISOTHIOCYANATE; IMPLANTS, EXPERIMENTAL; INFLAMMATION; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; IRIS; KIDNEY; NANOPARTICLES; PROSTHESIS IMPLANTATION; RABBITS; TRABECULAR MESHWORK; VITREOUS BODY;

EID: 83355168599     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028720     Document Type: Article

References (82)

1. Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, et al. (2003) Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci 44: 3562-3569.
2. Janoria KG, Gunda S, Boddu SH, Mitra AK, (2007) Novel approaches to retinal drug delivery. Expert Opin Drug Deliv 4: 371-388.
3. Nair A, Thevenot P, Hu W, Tang L, (2008) Nanotechnology in the Treatment and Detection of Intraocular Cancers. J Biomed Nanotechnol 4: 410-418.
4. Kaur IP, Kanwar M, (2002) Ocular preparations: the formulation approach. Drug Dev Ind Pharm 28: 473-493.
5. Sakurai E, Ozeki H, Kunou N, Ogura Y, (2001) Effect of particle size of polymeric nanospheres on intravitreal kinetics. Ophthalmic Res 33: 31-36.
6. Choonara YE, Pillay V, Danckwerts MP, Carmichael TR, du Toit LC, (2010) A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases. J Pharm Sci 99: 2219-2239.
7. Hsu J, (2007) Drug delivery methods for posterior segment disease. Curr Opin Ophthalmol 18: 235-239.
8. Vandervoort J, Ludwig A, (2007) Ocular drug delivery: nanomedicine applications. Nanomedicine (Lond) 2: 11-21.
9. Li H, Tran VV, Hu Y, Saltzman WM, Barnstable CJ, et al. (2006) A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres. Exp Eye Res 83: 824-833.
10. Merodio M, Irache JM, Valamanesh F, Mirshahi M, (2002) Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials 23: 1587-1594.
11. Padilla De Jesus OL, Ihre HR, Gagne L, Frechet JM, Szoka FC Jr, (2002) Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjug Chem 13: 453-461.
12. Vega E, Egea MA, Valls O, Espina M, Garcia ML, (2006) Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration. J Pharm Sci 95: 2393-2405.
13. Amrite AC, Kompella UB, (2005) Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol 57: 1555-1563.
14. Hsiue GH, Hsu SH, Yang CC, Lee SH, Yang IK, (2002) Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide. Biomaterials 23: 457-462.
15. Lim JI, Wolitz RA, Dowling AH, Bloom HR, Irvine AR, et al. (1999) Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 127: 288-293.
16. Sahoo SK, Dilnawaz F, Krishnakumar S, (2008) Nanotechnology in ocular drug delivery. Drug Discov Today 13: 144-151.
17. Irache JM, Merodio M, Arnedo A, Camapanero MA, Mirshahi M, et al. (2005) Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs. Mini Rev Med Chem 5: 293-305.
18. Huhtala A, Pohjonen T, Salminen L, Salminen A, Kaarniranta K, et al. (2008) In vitro biocompatibility of degradable biopolymers in cell line cultures from various ocular tissues: extraction studies. J Mater Sci Mater Med 19: 645-649.
19. Kawakami S, Harada A, Sakanaka K, Nishida K, Nakamura J, et al. (2004) In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits. Int J Pharm 278: 255-262.
20. Kawashima Y, Niwa T, Handa T, Takeuchi H, Iwamoto T, et al. (1989) Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. J Pharm Sci 78: 68-72.
21. Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G, (2002) Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 23: 3247-3255.
22. Quintana A, Raczka E, Piehler L, Lee I, Myc A, et al. (2002) Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 19: 1310-1316.
23. Kamath S, Bhattacharyya D, Padukudru C, Timmons RB, Tang L, (2008) Surface chemistry influences implant-mediated host tissue responses. J Biomed Mater Res A 86: 617-626.
24. Liu H, Webster TJ, (2006) Nanomedicine for implants: A review of studies and necessary experimental tools. Biomaterials 28: 354-369.
25. Nair A, Zou L, Bhattacharyya D, Timmons RB, Tang L, (2008) Species and density of implant surface chemistry affect the extent of foreign body reactions. Langmuir 24: 2015-2024.
26. Roach P, Eglin D, Rohde K, Perry CC, (2007) Modern biomaterials: a review- bulk properties and implications of surface modifications. J Mater Sci Mater Med 18: 1263-1277.
27. Thevenot P, Hu W, Tang L, (2008) Surface chemistry influences implant biocompatibility. Curr Top Med Chem 8: 270-280.
28. Nguyen KT, Shukla KP, Moctezuma M, Braden AR, Zhou J, et al. (2009) Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cells. J Biomed Mater Res A 88: 1022-1030.
29. Sakuma S, Sudo R, Suzuki N, Kikuchi H, Akashi M, et al. (1999) Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int J Pharm 177: 161-172.
30. Fessi H, Devissaguet JP, Puisieus F, Thies C, (1986) Proédé de préparation de systèmes colloidaux dispersibles d'une substance, sous forme de nanoparticles. In: French Patent 2, 988, editor. France.
31. Fessi H, Puisieus F, Devissaguet JP, Ammoury N, Benita S, (1989) Nanocapsule formation by interfacial polymer deposition following solvent displacement. International Journal of Pharmaceutics 55: R1-R4.
32. Riley T, Govender T, Stolnik S, Xiong CD, Garnett MC, et al. (1999) Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles. Colloids and Surfaces B: Biointerfaces 16: 147-159.
33. Cejkova J, Hanus J, Stepanek F, (2010) Investigation of internal microstructure and thermo-responsive properties of composite PNIPAM/silica microcapsules. J Colloid Interface Sci 346: 352-360.
34. Gao Q, Wang C, Liu H, Wang C, Liu X, et al. (2009) Suspension polymerization based on inverse Pickering emulsion droplets for thermo-sensitive hybrid microcapsules with tunable supracolloidal structures. Polymer 50: 2587-2594.
35. Hu Z, Xia X, Tang L, (2009) Process for synthesizing oil and surfactant-free hyaluronic acid nanoparticles and microparticles United States of America University of North Texas (Denton, TX, US).
36. Ma WJ, Li XR, Li YX, Xue ZX, Yin HJ, et al. (2011) Antiinflammatory effect of low-level laser therapy on Staphylococcus epidermidis endophthalmitis in rabbits. Lasers Med Sci.
37. Nishida K, Kamei M, Du ZJ, Xie P, Yamamoto T, et al. (2011) Safety threshold of intravitreal activated protein-C. Graefes Arch Clin Exp Ophthalmol 249: 833-838.
38. Johnson M, Kass MA, Moses RA, Grodzki WJ, (1978) Increased corneal thickness simulating elevated intraocular pressure. Arch Ophthalmol 96: 664-665.
39. Ponte F, Giuffre G, Giammanco R, Dardanoni G, (1994) Risk factors of ocular hypertension and glaucoma. The Casteldaccia Eye Study. Doc Ophthalmol 85: 203-210.
40. Urcola JH, Hernandez M, Vecino E, (2006) Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death. Exp Eye Res 83: 429-437.
41. Nair A, Thevenot P, Dey J, Shen J, Sun MW, et al. (2010) Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Eng Part C Methods 16: 23-32.
42. Thevenot PT, Nair AM, Shen J, Lotfi P, Ko CY, et al. (2010) The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 31: 3997-4008.
43. Raju HB, Hu Y, Vedula A, Dubovy SR, Goldberg JL, (2011) Evaluation of magnetic micro- and nanoparticle toxicity to ocular tissues. PLoS One 6: e17452.
44. Akler ME, Johnson DW, Burman WJ, Johnson SC, (1998) Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. Ophthalmology 105: 651-657.
45. Khoobehi B, Stradtmann MO, Peyman GA, Aly OM, (1991) Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection. Ophthalmic Surg 22: 175-180.
46. Lloyd AW, Faragher RG, Denyer SP, (2001) Ocular biomaterials and implants. Biomaterials 22: 769-785.
47. Lu JM, Wang X, Marin-Muller C, Wang H, Lin PH, et al. (2009) Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 9: 325-341.
48. Amrite AC, Edelhauser HF, Singh SR, Kompella UB, (2008) Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis 14: 150-160.
49. Fitzpatrick SD, Jafar Mazumder MA, Lasowski F, Fitzpatrick LE, Sheardown H, (2010) PNIPAAm-grafted-collagen as an injectable, in situ gelling, bioactive cell delivery scaffold. Biomacromolecules 11: 2261-2267.
50. Nair A, Shen J, Thevenot P, Zou L, Cai T, et al. (2008) Enhanced intratumoral uptake of quantum dots concealed within hydrogel nanoparticles. Nanotechnology 19: 485102.
51. Cao Y, Zhang C, Shen W, Cheng Z, Yu LL, et al. (2007) Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Release 120: 186-194.
52. Kaneko M, (1987) Interphotoreceptor matrix glycosaminoglycans in bovine eye. Ophthalmic Res 19: 330-337.
53. Weng H, Zhou J, Tang L, Hu Z, (2004) Tissue responses to thermally-responsive hydrogel nanoparticles. J Biomater Sci Polym Ed 15: 1167-1180.
54. Yasukawa T, Ogura Y, Sakurai E, Tabata Y, Kimura H, (2005) Intraocular sustained drug delivery using implantable polymeric devices. Adv Drug Deliv Rev 57: 2033-2046.
55. Beeley NR, Rossi JV, Mello-Filho PA, Mahmoud MI, Fujii GY, et al. (2005) Fabrication, implantation, elution, and retrieval of a steroid-loaded polycaprolactone subretinal implant. J Biomed Mater Res A 73: 437-444.
56. Liao YH, Jones SA, Forbes B, Martin GP, Brown MB, (2005) Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv 12: 327-342.
57. Prabaharan M, Mano JF, (2005) Chitosan-based particles as controlled drug delivery systems. Drug Delivery 12: 41-57.
58. Lai JY, Ma DH, Cheng HY, Sun CC, Huang SJ, et al. (2010) Ocular biocompatibility of carbodiimide cross-linked hyaluronic acid hydrogels for cell sheet delivery carriers. J Biomater Sci Polym Ed 21: 359-376.
59. Lu PL, Lai JY, Tabata Y, Hsiue GH, (2008) A methodology based on the "anterior chamber of rabbit eyes" model for noninvasively determining the biocompatibility of biomaterials in an immune privileged site. J Biomed Mater Res A 86: 108-116.
60. Binkhorst CD, (1980) Inflammation and intraocular pressure after the use of Healon in intraocular lens surgery. J Am Intraocul Implant Soc 6: 340-341.
61. Musa F, Srinivasan S, King CM, Kamal A, (2006) Raised intraocular pressure and orbital inflammation: a rare IgE-mediated allergic reaction to sub-Tenon's hyaluronidase. J Cataract Refract Surg 32: 177-178.
62. Taniguchi T, Kawakami H, Sawada A, Iwaki M, Tsuji A, et al. (1998) Effects of nitric oxide synthase inhibitor on intraocular pressure and ocular inflammation following laser irradiation in rabbits. Curr Eye Res 17: 308-315.
63. Williamson J, Eilon LA, Walker SR, (1981) Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure. Trans Ophthalmol Soc U K 101: 27-29.
64. Dietlein TS, (2003) [Glaucoma and uveitis. Causes of and treatment options for increased intraocular pressure in cases of inflammatory ophthalmology]. Ophthalmologe 100: 991-1006; quiz 1007-1008.
65. Davis JL, Taskintuna I, Freeman WR, Weinberg DV, Feuer WJ, et al. (1997) Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol 115: 733-737.
66. Herbert HM, Viswanathan A, Jackson H, Lightman SL, (2004) Risk factors for elevated intraocular pressure in uveitis. J Glaucoma 13: 96-99.
67. Kinshuck D, (1991) Glauline (metipranolol) induced uveitis and increase in intraocular pressure. Br J Ophthalmol 75: 575.
68. Ohno S, Ichiishi A, Matsuda H, (1989) Hypotensive effect of carteolol on intraocular pressure elevation and secondary glaucoma associated with endogenous uveitis. Ophthalmologica 199: 41-45.
69. Fernandez-Cossio S, Castano-Oreja MT, (2006) Biocompatibility of two novel dermal fillers: histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler. Plast Reconstr Surg 117: 1789-1796.
70. Kamelger FS, Marksteiner R, Margreiter E, Klima G, Wechselberger G, et al. (2004) A comparative study of three different biomaterials in the engineering of skeletal muscle using a rat animal model. Biomaterials 25: 1649-1655.
71. Avitabile T, Marano F, Castiglione F, Bucolo C, Cro M, et al. (2001) Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits. Biomaterials 22: 195-200.
72. Amrite AC, Ayalasomayajula SP, Kompella UB, (2003) Ocular Distribution of Intact Nano- & MicroParticles Following Subconjunctival & Systemic Routes of Administration. Drug Development and Delivery 3.
73. Insler MS, Helm CJ, George WJ, (1987) Topical vs systemic gentamicin penetration into the human cornea and aqueous humor. Arch Ophthalmol 105: 922-924.
74. Ueda J, Sawaguchi S, Hanyu T, Yaoeda K, Fukuchi T, et al. (1998) Experimental glaucoma model in the rat induced by laser trabecular photocoagulation after an intracameral injection of India ink. Jpn J Ophthalmol 42: 337-344.
75. Einmahl S, Ponsart S, Bejjani RA, D'Hermies F, Savoldelli M, et al. (2003) Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation. J Biomed Mater Res A 67: 44-53.
76. Giordano GG, Chevez-Barrios P, Refojo MF, Garcia CA, (1995) Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres. Curr Eye Res 14: 761-768.
77. Cheng L, Anglin E, Cunin F, Kim D, Sailor MJ, et al. (2008) Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle. Br J Ophthalmol 92: 705-711.
78. Fleenor DL, Shepard AR, Hellberg PE, Jacobson N, Pang IH, et al. (2006) TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci 47: 226-234.
79. Kymionis GD, Diakonis VF, Charisis S, Pallikaris AI, Bouzoukis DI, et al. (2008) Effects of topical mitomycin C on the ciliary body and intraocular pressure after PRK: an experimental study. J Refract Surg 24: 633-638.
80. Rosa N, Lanza M, Borrelli M, De Bernardo M, Palladino A, et al. (2011) Low intraocular pressure resulting from ciliary body detachment in patients with myotonic dystrophy. Ophthalmology 118: 260-264.
81. Stoiber J, Fernandez V, Lamar PD, Decker SJ, Dubovy S, et al. (2005) Trabecular meshwork alteration and intraocular pressure change following pulsed near-infrared laser trabeculoplasty in cats. Ophthalmic Surg Lasers Imaging 36: 471-481.
82. Ambati J, Wynne KB, Angerame MC, Robinson MR, (1999) Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis. Br J Ophthalmol 83: 1153-1158.